Julie Zhen Qin Wu

Array ( [id] => 9113057 [patent_doc_number] => 08569226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'High affinity metal-oxide binding peptides with reversible binding' [patent_app_type] => utility [patent_app_number] => 12/678911 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 15207 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202844 [patent_doc_number] => 20110065630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'USE OF A OCTREOTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677293 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34796 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065630.pdf [firstpage_image] =>[orig_patent_app_number] => 12677293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033062 [patent_doc_number] => 20110082079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'GLUCAGON-LIKE PEPTIDE-1 DERIVATIVES AND THEIR PHARMACEUTICAL USE' [patent_app_type] => utility [patent_app_number] => 12/676451 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38425 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082079.pdf [firstpage_image] =>[orig_patent_app_number] => 12676451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515680 [patent_doc_number] => 20090215987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'PEPTIDE AMIDATION PROCESS' [patent_app_type] => utility [patent_app_number] => 12/199902 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7267 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215987.pdf [firstpage_image] =>[orig_patent_app_number] => 12199902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338009 [patent_doc_number] => 20090054473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'THERAPY FOR COMPLICATIONS OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/196635 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16166 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054473.pdf [firstpage_image] =>[orig_patent_app_number] => 12196635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149828 [patent_doc_number] => 20110021423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Rapid Acting Insulin Analogues' [patent_app_type] => utility [patent_app_number] => 12/673226 [patent_app_country] => US [patent_app_date] => 2008-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10219 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021423.pdf [firstpage_image] =>[orig_patent_app_number] => 12673226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039377 [patent_doc_number] => 20110092426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'ORAL CALCITONIN COMPOSITIONS AND APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/672760 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5477 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092426.pdf [firstpage_image] =>[orig_patent_app_number] => 12672760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146869 [patent_doc_number] => 08163874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Beta helical peptide structures stable in aqueous and non-aqueous media and methods for preparing same' [patent_app_type] => utility [patent_app_number] => 12/187308 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 9235 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163874.pdf [firstpage_image] =>[orig_patent_app_number] => 12187308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9350338 [patent_doc_number] => 08669229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Benzazepine derivatives useful as vasopressin antagonists' [patent_app_type] => utility [patent_app_number] => 12/666751 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23827 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12666751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637058 [patent_doc_number] => 20100173832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'ANTICANCEROUS POLYMERIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/451179 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27521 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173832.pdf [firstpage_image] =>[orig_patent_app_number] => 12451179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064154 [patent_doc_number] => 20110201548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'THERAPEUTIC AGENT FOR ACUTE HEPATITIS OR PROPHYLACTIC/THERAPEUTIC AGENT FOR FULMINANT HEPATITIS' [patent_app_type] => utility [patent_app_number] => 12/450835 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8330 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201548.pdf [firstpage_image] =>[orig_patent_app_number] => 12450835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937358 [patent_doc_number] => 20110212897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'WNT3A FOR INHIBITION OF SCARRING' [patent_app_type] => utility [patent_app_number] => 12/527182 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24502 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212897.pdf [firstpage_image] =>[orig_patent_app_number] => 12527182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953856 [patent_doc_number] => 20110034387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'POLYPEPTIDE INHIBITING ANGIOGENESIS AND APPLICATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/866166 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7139 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034387.pdf [firstpage_image] =>[orig_patent_app_number] => 12866166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710807 [patent_doc_number] => 08835375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Cyclic angiotensin analogs' [patent_app_type] => utility [patent_app_number] => 12/376606 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 13432 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12376606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220069 [patent_doc_number] => 20100055164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'SYNTHETIC LUNG SURFACTANT AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/374458 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21071 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055164.pdf [firstpage_image] =>[orig_patent_app_number] => 12374458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302057 [patent_doc_number] => 20100068150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Selective Caspase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/306215 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 24583 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068150.pdf [firstpage_image] =>[orig_patent_app_number] => 12306215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025742 [patent_doc_number] => 20110053827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'INTRANASAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 12/303667 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4782 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053827.pdf [firstpage_image] =>[orig_patent_app_number] => 12303667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585955 [patent_doc_number] => 20090105157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'PEPTIDE SUBSTANCE STIMULATING REGENERATION OF CENTRAL NERVOUS SYSTEM NEURONS, PHARMACEUTICAL COMPOSITION ON ITS BASE, AND THE METHOD OF ITS APPLICATION' [patent_app_type] => utility [patent_app_number] => 12/298420 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6753 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105157.pdf [firstpage_image] =>[orig_patent_app_number] => 12298420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543710 [patent_doc_number] => 20100016207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Methods and Compositions for Raising Levels and Release of Gamma Aminobutyric Acid' [patent_app_type] => utility [patent_app_number] => 12/084768 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9893 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016207.pdf [firstpage_image] =>[orig_patent_app_number] => 12084768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4822997 [patent_doc_number] => 20080227698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'OLIGOPEPTIDES FOR TREATMENT OF OSTEOPOROSIS AND OTHER BONE DISEASES AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 11/557292 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227698.pdf [firstpage_image] =>[orig_patent_app_number] => 11557292 [rel_patent_id] =>[rel_patent_doc_number] =>)